INS and obesity disorder: A previous study in mice found that GPHB5 overexpression improved diet-induced obesity, reduced the levels of blood glucose, triglycerides, cholesterol and insulin, and increased the levels of T3 and T4 (17), suggesting that it is involved in the process of energy equilibrium in vivo.